Cargando…
Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review
BACKGROUND: Inclusion of productivity losses and gains in cost-effectiveness analyses for drugs is recommended by pharmacoeconomic guidelines in some countries and is considered optional in others. Often guidelines recommend analysis based on the payer perspective, but suggest that a supplemental an...
Autores principales: | Yuasa, Akira, Yonemoto, Naohiro, LoPresti, Michael, Ikeda, Shunya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790765/ https://www.ncbi.nlm.nih.gov/pubmed/33230613 http://dx.doi.org/10.1007/s40273-020-00986-4 |
Ejemplares similares
-
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders
por: Yuasa, Akira, et al.
Publicado: (2022) -
A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria
por: Igarashi, Atsuyuki, et al.
Publicado: (2022) -
Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries
por: Yuasa, Akira, et al.
Publicado: (2020) -
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review
por: Wakutsu, Naohiko, et al.
Publicado: (2023) -
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
por: Li, Nannan, et al.
Publicado: (2020)